Oral Immunologic Diseases Recurrent Aphthous Stomatitis (Canker Sores R.A.S.)

Download as pdf or txt
Download as pdf or txt
You are on page 1of 12

Oral Immunologic Diseases

Dr. Ioannis G. Koutlas Division of Oral Pathology


All pictures are intellectual property of the Division of Oral and Maxillofacial Pathology or its Faculty. Duplication or any unauthorized use is prohibited.

Recurrent Aphthous Stomatitis (Canker Sores; R.A.S.)


Aphtha=Ulcer Cause unclear; recur in episodes Minor, major, herpetiform 20% of general population More often in females Clinical appearance and location are important

Recurrent Aphthous Stomatitis


Trauma can be precipitating factor Other factors include: food allergies, genetic predisposition, stress, nutritional deficiencies, hormonal influence, infectious agents, food (high acid content) Systemic disease: Inflammatory bowel disease (Crohn's disease & ulcerative colitis), Behcet's syndrome, leukopenia, allergy to gluten (gluten intolerance-sprue = celiac disease), cyclic neutropenia, immunocompromised status, MAGIC syndrome, PFAPA syndrome, Reiters disease, Sweet syndrome, ulcus vulvae acutum

Systemic Diseases
MAGIC syndrome: Mouth and genital ulcers & inflamed cartilage PFAPA: Periodic fever, aphthae, pharyngitits and adenitis Sweets syndrome: Acute febrile neutrophilic dermatosis
Fever Neutrophilic leukocytosis Erythematous skin plaques or nodules Classic RAS Conjunction with malignant conditions, e.g. leukemia

Minor Aphthae Recurrent Aphthous Stomatitis


NO FORMATION OF VESICLES/BULLAE

Substantial evidence of an immunologic pathogenesis Slightly elevated levels of antibodies to oral mucous membranes Cell-mediated immunity
T-helper cells in the early stage T-cytotoxic in ulcerative stage T-helper in healing stage

Most common Round oval ulcers up to 1 cm in diameter surfaced by yellow-white fibrin covering, surrounded by a halo of erythema Mucosa not covering bone, occasionally extending to the gingiva; anterior part of the mouth more often Early stage 1-2 days Burning sensation or soreness Heal in 7-21 days

Major Aphthae
Sutton's disease or periadenitis mucosa necrotica recurrens Larger than 1 cm Deeper and last longer Lips and posterior (faucial pillar, soft palate) May require biopsy
DD: Squamous cell carcinoma, fungal infection

Heal with scarring

Aphthous Stomatitis Herpetiformis


Demonstrate the greatest number; as many as 100 1-3 mm resembling herpes simplex virus ulcers Occur in groups and can coalesce Recurrences closely spaced Any oral site Female predominance

Treatment
No treatment Topical therapy for pain Systemic therapy for severe cases Topical steroids: betamethasone, fluocinonide, clobetasol propionate Many other therapies: colchicine, levamisole, dapsone, pentoxifylline,thalidomide, cytotoxic, MAO inhibitors, antibiotics, laser ablation Complex cases: Identification of the agent

Behet's Syndrome
Multisystem disease HLA-B51; bacteria, viruses, pesticides G.I. tract, cardiovascular system, C.N.S.(paralysis, dimentia), lungs, eyes (uveitis, conjunctivitis, cataracts, glaucoma), skin (erythema nodosum, pseudofolliculitis, acneiform nodules), and genitals (painful ulcers especially in men) Oral aphthae are a consistent feature Six or more; major aphthae high prevalence Pathergy testing

Sarcoidosis
Systemic chronic granulomatous disorder of unknown etiology (Mycobacterial infection ?) 10-15x in blacks, females, 20-40 years Dyspnea, chest pain, fatigue, arthralgia, weight loss Can arise insidiously; 20% of cases discovered after routine chest x-ray (hilar lymphadenopathy) Lungs: (Pulmonary hypertension & respiratory failure) Lymph nodes Skin: Lupus pernio, erythema nodosum Eyes: Keratoconjuctivitis sicca

Sarcoidosis
Lupus pernio: violaceous indurated lesions of the skin (nose, lips, face) Heerfordt's syndrome (Uveoparotid fever)
Parotid enlargement Anterior uveitis of the eye Facial paralysis Fever

Sarcoidosis
Oral involvement (can be first manifestation)
Isolated mass Multiple nodular growths Intraosseous lesions
Ill-defined radiolucencies Localized periodontal disease Can be first manifestation

Lfgren syndrome
Erythema nodosum Bilateral hilar lymphadenopathy Arthralgia

Minor salivary gland involvement, mucoceles

Sarcoidosis
Histopathology
Chronic granulomatous inflammation Calcifications (Schaumann bodies) Asteroid bodies

Laboratory tests
Kweim test
Historic, 50-80% accuracy, false positive

Angiotensin Converting Enzyme


Elevated

Treatment
No treatment Corticosteroids, other immunosuppressant medications

Orofacial Granulomatosis
Histologically: Non-specific granulomatous inflammation Includes Melkersson-Rosenthal syndrome and Miescher cheilitis Abnormal immune response

Systemic Diseases That May Mimic Orofacial Granulomatosis


Chronic granulomatous disease
X-linked, neutrophil microbicidal activity defective Early life onset Candidiasis, eczematous cheilitis, ANUG Quantitative nitroblue tetrazolium test (-), neutrophilic leukocytosis, hypergammaglobulinemia

Crohns disease Sarcoidosis Tuberculosis

Local Processes That Can Present As Orofacial Granulomatosis


Chronic oral infection Foreign material Allergy

Wegeners Granulomatosis
Necrotizing granulomatous lesion Respiratory tract Necrotizing glomerulonephritis Systemic vasculitis of small arteries and veins Hypersensitivity response to inhaled antigen? Secondary reaction to an infection Three types
Classic Limited Superficial

Wegeners Granulomatosis
URT: Nasal discharge, otitis media, sore throat, epistaxis, destruction of nasal septum LRT: Dry cough, dyspnea, hemoptysis, chest pain Kidneys: Glomerulonephritis, proteinuria, RBC casts Mouth
Strawberry gingivitis (unique); early and only Nonspecific ulcerations; late

Wegeners Granulomatosis Diagnosis


Clinical findings Histopathologic findings Laboratory tests
c-ANCA: Cytoplasmic antineutrophil cytoplasm Ab
1:80 (NL: 1:40) 90-95% (+) for acute generalized 60% for localized A rising titer during treatment indicates relapse

Wegeners Granulomatosis Treatment


Lethal without treatment
Mean survival: 5 months 80% dead at one year 90% dead by two years

c-ANCA/anti proteinase 3 Abs


97% specific; 90% sensitive

Cyclophosphamide (2mg/kg/day) and prednisone (1 mg/kg/day) Beclomethasone nasal spray Trimethoprim-sulfamethoxazole


Bacterial challenge for URT

p-ANCA: Perinuclear Elevated ESR, WBC, normocytic normochromatic anemia

Cyclosporine

Stomatitis Medicamentosa
Erythema multiforme Anaphylactic stomatitis Fixed drug eruption Lichenoid drug reaction Lupus erythematosus-like reaction Pemphigus-like eruption Non-specific vesiculoulcerative lesions

Stomatitis Medicamentosa
Detailed medical history Identify medications that have been associated with allergic responses OVER-THE-COUNTER MEDICATIONS Association may be acute and obvious or it may be delayed If more than one medication is suspected serial elimination may be indicated DO NOT WORK ALONE

Stomatitis Venenata
a.k.a. Contact stomatitis
Acute and chronic

Food and food additives, chewing gums, candies, mouthwashes, glove material (latex), anesthetics, dental impression material, denture adhesive preparations Rare because
Contact is brief Saliva dilutes and removes antigens Rapid dispersal and absorption Allergen may be not recognized

Stomatitis Venenata
If skin is sensitized, mouth may or may not demonstrate reaction If mouth is sensitized, skin usually demonstrates reaction Female predominance Small vesicles, aphthae, itching, edema, hyperkeratotic lesions, erythema and epithelial desquamation Types

Stomatitis Venenata
Exfoliative cheilitis or perioral dermatitis Plasma cell gingivitis
Cinnamon, other herbs

Contact stomatitis due to cinnamon and mint


Shaggy hyperkeratosis and erythema

Contact stomatitis due to dental amalgam


Lichenoid lesions opposite to restoration

10

Perioral Dermatitis
Corticosteroids worsen the lesions Tartar control toothpastes, bubble gum moisturizers, night creams, cosmetic products; in adults ~90% women Irritant or skin occlusion and flora proliferation Zone of spared skin adjacent to vermilion Perinasal, periorbital lesions Circumoral dermatitis

11

Angioedema (Angioneurotic edema)


Patients are not neurotic Mast cell degranulation ACE inhibitors (captopril, enalapril, lisinopril) drug reactions Activation of complement
Hereditary
Quantitative reduction in the inhibitor that prevents transformation of C1 to C1 esterase Dysfunctional inhibitor

Acquired
Lymphoproliferative disorders; formation of autoantibodies; minor trauma Lupus erythematosus Peripheral eosinophilia

Angioedema (Angioneurotic edema)


Antihistamines Intramuscular epinephrine Intravenous steroids ACE inhibitors should be avoided if implicated C1-INH deficiency
Avoid vigorous exercise and trauma Danazol or stanozolol (adrogens) Corticosteroids

12

You might also like